Frontlight ResearchEarly access
CompletedEarly phase 1
Testing an Adjustable Ankle Orthosis During Walking in Cerebral Palsy
Key facts
- Who runs it
- Northern Arizona University
- Where
- Flagstaff, United StatesSee the site
- Trial code
- Status
- Completed
- Phase
- Early phase 1
- People taking part
- 11 people enrolled
- Started
- 1 May 2024
- Ended
- 1 Jun 2024
- Type of study
- Interventional
- Treatments tested
- Differential and adjustable stiffness AFO (DAS-AFO)
- Record updated
- 25 May 2025
Who can take part
- Age
- 8 years to 35 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Age between 8-35 years old, inclusive
- Diagnosis of cerebral palsy (CP)
- Gross motor functional classification score level I, II, or III
- Physician-prescribed AFOs of common design (i.e., rigid molded thermoplastic)
- Ability to walk for 6 minutes on a treadmill
- At least 20° of passive plantar-flexion range of motion
- No concurrent treatment other than those assigned during the study
- No condition other than CP that would affect safe participation
- No surgery within 6 months of participation
Who cannot take part
- -Excessive knee flexion during walking caused by CP
Where in United States
- Northern Arizona UniversityFlagstaff, United States
About the trial
What the trial wants to find out
This study seeks to determine how an adjustable stiffness ankle braces affects walking performance and biomechanics in cerebral palsy.
The group in the trial
- Study groupTreatment being tested
Participants will walk with the new AFO, their own AFOs, and no AFOs.
Treatment: Differential and adjustable stiffness AFO (DAS-AFO)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- An Adjustable Stiffness Orthosis to Maintain Muscle Engagement and Push-off Power in Cerebral Palsy
- Record updated
- 25 May 2025